Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famitinib in Advanced Colorectal Adenocarcinoma
NCT02390947Phase 3Completed
- Sponsor
- Hengrui
- Start
- Jan 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of famitinib in colorectal adenocarcinoma, sponsored by Hengrui. Started Jan 2015; status: completed.
02
Drugs
famitinib
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT02390947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390947.